CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Inventory, Finished Goods, Net of Reserves
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Inventory, Finished Goods, Net of Reserves of $254.11 million as of 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2026-08-05
- 2026-06-27: Inventory, Finished Goods, Net of Reserves $254.11M.
- 2026-03-28: Inventory, Finished Goods, Net of Reserves $275.45M.
- 2025-12-27: Inventory, Finished Goods, Net of Reserves $169.40M.
- 2025-09-27: Inventory, Finished Goods, Net of Reserves $198.14M.
| Period end | Inventory, Finished Goods, Net of Reserves |
|---|---|
| 2026-06-27 | $254.11M 10-Q · filed 2026-08-05 |
| 2026-03-28 | $275.45M 10-Q · filed 2026-05-07 |
| 2025-12-27 | $169.40M 10-Q · filed 2026-08-05 |
| 2025-09-27 | $198.14M 10-Q · filed 2025-11-05 |
| 2025-06-28 | $195.75M 10-Q · filed 2025-08-06 |
| 2025-03-29 | $192.38M 10-Q · filed 2025-05-07 |
| 2024-12-28 | $183.72M 10-K · filed 2026-02-18 |
| 2024-09-28 | $243.96M 10-Q · filed 2024-11-06 |
| 2024-06-29 | $247.95M 10-Q · filed 2024-08-07 |
| 2024-03-30 | $273.43M 10-Q · filed 2024-05-09 |
| 2023-12-30 | $278.24M 10-K · filed 2025-02-19 |
| 2023-09-30 | $205.76M 10-Q · filed 2023-11-08 |
| 2023-07-01 | $202.75M 10-Q · filed 2023-08-09 |
| 2023-04-01 | $184.98M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $168.55M 10-K · filed 2024-02-14 |
| 2022-09-24 | $184.57M 10-Q · filed 2022-11-02 |
| 2022-06-25 | $175.91M 10-Q · filed 2022-08-03 |
| 2022-03-26 | $150.76M 10-Q · filed 2022-05-04 |
| 2021-12-25 | $125.76M 10-K · filed 2023-02-22 |
| 2021-09-25 | $122.00M 10-Q · filed 2021-11-03 |
| 2021-06-26 | $133.96M 10-Q · filed 2021-08-04 |
| 2021-03-27 | $134.24M 10-Q · filed 2021-05-04 |
| 2020-12-26 | $120.62M 10-K · filed 2022-02-16 |
| 2020-09-26 | $120.39M 10-Q · filed 2020-10-29 |
| 2020-06-27 | $106.32M 10-Q · filed 2020-08-05 |
| 2020-03-28 | $107.81M 10-Q · filed 2020-05-07 |
| 2019-12-28 | $100.19M 10-K · filed 2021-02-17 |
| 2019-09-28 | $95.00M 10-Q · filed 2019-11-06 |
| 2019-06-29 | $87.53M 10-Q · filed 2019-07-31 |
| 2019-03-30 | $86.94M 10-Q · filed 2019-05-07 |
| 2018-12-29 | $83.78M 10-K · filed 2020-02-11 |
| 2018-09-29 | $84.47M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $82.89M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $79.61M 10-Q · filed 2018-05-10 |
| 2017-12-30 | $76.90M 10-K · filed 2019-02-13 |
| 2017-09-30 | $74.95M 10-Q · filed 2017-11-09 |
| 2017-07-01 | $71.60M 10-Q · filed 2017-08-09 |
| 2017-04-01 | $69.23M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $63.26M 10-K · filed 2018-02-13 |
| 2016-09-24 | $66.81M 10-Q · filed 2016-11-02 |
| 2016-06-25 | $67.17M 10-Q · filed 2016-08-03 |
| 2016-03-26 | $65.61M 10-Q · filed 2016-05-04 |
| 2015-12-26 | $65.64M 10-K · filed 2017-02-14 |
| 2015-09-26 | $69.50M 10-Q · filed 2015-11-04 |
| 2015-06-27 | $64.13M 10-Q · filed 2015-07-30 |
| 2015-03-28 | $61.65M 10-Q · filed 2015-04-30 |
| 2014-12-27 | $61.83M 10-K · filed 2016-02-12 |
| 2014-09-27 | $65.06M 10-Q · filed 2014-10-30 |
| 2014-06-28 | $62.99M 10-Q · filed 2014-08-07 |
| 2014-03-29 | $64.69M 10-Q · filed 2014-04-30 |
| 2013-12-28 | $62.65M 10-K · filed 2015-02-17 |
| 2013-09-28 | $61.59M 10-Q · filed 2013-10-30 |
| 2013-06-29 | $61.28M 10-Q · filed 2013-07-31 |
| 2013-03-30 | $60.70M 10-Q · filed 2013-05-08 |
| 2012-12-29 | $62.86M 10-K · filed 2014-02-25 |
| 2012-09-29 | $66.16M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $62.66M 10-Q · filed 2012-08-07 |
| 2012-03-31 | $62.17M 10-Q · filed 2012-05-04 |
| 2011-12-31 | $65.45M 10-K · filed 2013-02-27 |
| 2011-09-24 | $65.05M 10-Q · filed 2011-11-02 |
| 2011-06-25 | $68.06M 10-Q · filed 2011-08-03 |
| 2010-12-25 | $73.28M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |